NCT01654536 · Interventional trial
A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)
Overall registry status Completed
Phase 4
Conditions Perennial Allergic Rhinitis
Delaware Valley sites
- Asthma and Allergy Research Associates · Upland, PA · Delaware County
First posted
Registry updated
Added to the directory